AURKA against 1
Product Specifications
Target
Aurora Kinase
Related Pathways
Cell Cycle/Checkpoint|||Chromatin/Epigenetic
Bioactivity
Compound Ac13, also termed AURKA against 1, acts as an inhibitor of the Aurora kinase (AURKA) with an IC50 of less than 0.5 nM, targeting the acetylation of endogenous lysine (K162) and exhibiting anti-tumor cell proliferation activity. The kinase activity of AURKA, acetylated at K162 and induced by AURKA against 1, is reversibly restored in HCT116 cells transfected with SIRT3.
Molecular Formula
C28H32FN9O2
Molecular Weight
545.61
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/240554098103943182/T89903
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![4-Chlorothieno[2,3-d]pyrimidine](https://cdn.genprice.uk/genprice/genprice4.png)
![4-Chlorothieno[2,3-d]pyrimidine](https://cdn.genprice.uk/genprice/genprice5.png)
![CPS1, NT (CPS1, Carbamoyl-phosphate synthase [ammonia], mitochondrial, Carbamoyl-phosphate synthetase I) (MaxLight 550)](https://cdn.genprice.uk/genprice/genprice3.png)
MBS6288402-01 0.1 mL
CPS1, NT (CPS1, Carbamoyl-phosphate synthase [ammonia], mitochondrial, Carbamoyl-phosphate synthetase I) (MaxLight 550)
Ask
View Details MBS6288402-02 5x 0.1 mL
CPS1, NT (CPS1, Carbamoyl-phosphate synthase [ammonia], mitochondrial, Carbamoyl-phosphate synthetase I) (MaxLight 550)
Ask
View Details